The DOI matches its Crossref record.
Strategies for the Prevention of Early-Onset Neonatal Group B Streptococcal Sepsis: A Decision Analysis
Abstract
OBJECTIVE: To perform a decision analysis to understand better the implications of 19 potential group B streptococcus screening and treatment strategies. METHODS: We searched the literature to locate appropriate articles from which to derive probability estimates. Using decision analysis, we determined the likely outcomes of 19 group B streptococcus screening and treatment strategies and focused on three main outcomes: 1) number of expected cases of early-onset neonatal group B streptococcal sepsis, 2) percentage of gravidas treated with intrapartum antibiotics, and 3) total costs. RESULTS: The strategy recently recommended by two committees of the American Academy of Pediatrics (universal 28-week maternal rectovaginal group B streptococcal culture and treatment of culture-positive, high-risk patients in labor) is among the least effective at reducing neonatal sepsis and the most costly. Strategies based on the currently available rapid streptococcus identification tests are ineffective at reducing neonatal sepsis and are costly. Three strategies outperform the rest: 1) Universal intrapartum maternal antibiotic treatment is the most effective strategy in reducing early-onset neonatal group B streptococcal sepsis (6% of expected) and is also the least costly; 2) intrapartum treatment based solely on risk factors (recently endorsed by ACOG) lowers the rate of neonatal sepsis to 31% of expected with an 18% maternal treatment rate and low total costs; and 3) universal 36-week maternal culture, and treatment of all patients experiencing preterm birth and all culture-positive patients results in 14% of expected neonatal sepsis, with a 27% maternal treatment rate and low total costs. CONCLUSION: Given the present state of knowledge, three strategies emerge from this decision analysis as most optimal for the prevention of early-onset neonatal group B streptococcal sepsis: universal treatment, treatment based on risk factors, and treatment based on preterm delivery and 36-week culture status.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Group B Streptococcal Disease in the Era of Intrapartum Antibiotic Prophylaxis
Schrag, S. J., Zywicki, S., Farley, M. M., Reingold, A. L., Harrison, L. H., Lefkowitz, L. B., Hadler, J. L., Danila, R., Cieslak, P. R., & Schuchat, A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200001063420103 · Cited by 1,024
Goldenberg, R. L., & Rouse, D. J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807303390506 · Cited by 758
Self-citationPrevention of Perinatal Group B Streptococcal Disease: A Public Health Perspective: (547302006-001)
(1996) · PsycEXTRA Dataset · doi:10.1037/e547302006-001 · Cited by 709
Schrag, S. J., Zell, E. R., Lynfield, R., Roome, A., Arnold, K. E., Craig, A. S., Harrison, L. H., Reingold, A., Stefonek, K., Smith, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020205 · Cited by 617
Epidemiology of Group B Streptococcal Disease in the United States: Shifting Paradigms
Schuchat, A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.3.497 · Cited by 609
Metadata
- Authors
- ROUSE, D. J., GOLDENBERG, R. L., CLIVER, S. P., CUTTER, G. R., MENNEMEYER, S. T., & FARGASON, C. A.
- Venue
- Obstetrics & Gynecology
- Published
- 1994-04
- Volume
- 83
- Issue
- 4
- Pages
- 483-494
- ISSN
- 0029-7844 (ISSN-L)
- OpenAlex
- W1996095950
- Cited by
- 204
- References
- 0
- FWCI
- 25.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Strategies for the Prevention of Early-Onset Neonatal Group B Streptococcal Sepsis: A Decision Analysis. https://app.cochat.ai/papers/10.1097/00006250-199404000-00001
- The paper
- ROUSE, D. J., GOLDENBERG, R. L., CLIVER, S. P., CUTTER, G. R., MENNEMEYER, S. T., & FARGASON, C. A. (1994). Strategies for the Prevention of Early-Onset Neonatal Group B Streptococcal Sepsis: A Decision Analysis. Obstetrics & Gynecology. https://doi.org/10.1097/00006250-199404000-00001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.